Dietary proanthocyanidins boost hepatic NAD + metabolism and SIRT1 expression and activity in a dose-dependent manner in healthy rats

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Aragonès, Gerard ^a   Suárez, Manuel ^a   Ardid Ruiz, Andrea ^a   Vinaixa, Maria ^a   Rodríguez, Miguel A ^a   Correig, Xavier ^a   Arola, Lluís ^a   Bladé, Cinta ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROANTHOCYANIDIN; SIRT1 PROTEIN, RAT; SIRTUIN 1;

ANIMAL; CHEMISTRY; DIETARY SUPPLEMENT; GENETICS; LIVER; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT;

ANIMALS; DIETARY SUPPLEMENTS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; NAD; PROANTHOCYANIDINS; RATS; RNA, MESSENGER; SIRTUIN 1;

EID: 84964294773     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24977     Document Type: Article

References (52)

1. Del Rio, D. et al. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal. 18, 1818-92 (2013).
2. Del Bas, J. M. et al. Grape seed procyanidins improve atherosclerotic risk index and induce liver CYP7A1 and SHP expression in healthy rats. FASEB J. 19, 479-81 (2005).
3. Pinent, M. et al. Procyanidin Effects on Adipocyte-Related Pathologies. Crit. Rev. Food Sci. Nutr. 46, 543-550 (2006).
4. Quesada, H. et al. Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver. Int. J. Obes. (Lond). 33, 1007-12 (2009).
5. Terra, X. et al. Modulatory effect of grape-seed procyanidins on local and systemic inflammation in diet-induced obesity rats. J. Nutr. Biochem. 22, 380-7 (2011).
6. Caimari, A., del Bas, J. M., Crescenti, A. & Arola, L. Low doses of grape seed procyanidins reduce adiposity and improve the plasma lipid profile in hamsters. Int. J. Obes. 37, 576-583 (2012).
7. Pons, Z., Margalef, M., Bravo, F. I., Arola-Arnal, A. & Muguerza, B. Acute administration of single oral dose of grape seed polyphenols restores blood pressure in a rat model of metabolic syndrome: role of nitric oxide and prostacyclin. Eur. J. Nutr. 55, 749-58 (2015).
8. Baiges, I., Palmfeldt, J., Bladé, C., Gregersen, N. & Arola, L. Lipogenesis is decreased by grape seed proanthocyanidins according to liver proteomics of rats fed a high fat diet. Mol. Cell. Proteomics 9, 1499-513 (2010).
9. Yogalakshmi, B., Sreeja, S., Geetha, R., Radika, M. K. & Anuradha, C. V. Grape seed proanthocyanidin rescues rats from steatosis: a comparative and combination study with metformin. J. Lipids 2013, 153897 (2013).
10. Fernández-Iglesias, A. et al. Grape seed proanthocyanidin extract improves the hepatic glutathione metabolism in obese Zucker rats. Mol. Nutr. Food Res. 58, 727-37 (2014).
11. Del Bas, J. M. et al. Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner. Mol. Nutr. Food Res. 53, 805-14 (2009).
12. Baselga-Escudero, L. et al. Chronic supplementation of proanthocyanidins reduces postprandial lipemia and liver miR-33a and miR-122 levels in a dose-dependent manner in healthy rats. J. Nutr. Biochem. 25, 151-6 (2014).
13. Baselga-Escudero, L. et al. Resveratrol and EGCG bind directly and distinctively to miR-33a and miR-122 and modulate divergently their levels in hepatic cells. Nucleic Acids Res. 42, 882-92 (2014).
14. Pan, M.-H., Lai, C.-S., Wu, J.-C. & Ho, C.-T. Epigenetic and disease targets by polyphenols. Curr. Pharm. Des. 19, 6156-85 (2013).
15. Patti, G. J., Yanes, O. & Siuzdak, G. Innovation: Metabolomics: the apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol. 13, 263-9 (2012).
16. Vinaixa, M. et al. Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease. J. Proteome Res. 9, 2527-38 (2010).
17. Rull, A. et al. Metabolic phenotyping of genetically modified mice: An NMR metabonomic approach. Biochimie 91, 1053-7 (2009).
18. Rull, A. et al. Rosiglitazone and fenofibrate exacerbate liver steatosis in a mouse model of obesity and hyperlipidemia. A transcriptomic and metabolomic study. J. Proteome Res. 13, 1731-43 (2014).
19. van Ommen, B., Keijer, J., Heil, S. G. & Kaput, J. Challenging homeostasis to define biomarkers for nutrition related health. Mol. Nutr. Food Res. 53, 795-804 (2009).
20. Calnan, D. R. & Brunet, A. The FoxO code. Oncogene 27, 2276-88 (2008).
21. Bordone, L. et al. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. 4, e31 (2006).
22. Ribas-Latre, A. et al. Dietary proanthocyanidins modulate BMAL1 acetylation, Nampt expression and NAD levels in rat liver. Sci. Rep. 5, 10954 (2015).
23. Cantó, C., Menzies, K. J. & Auwerx, J. NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metab. 22, 31-53 (2015).
24. Cantó, C. et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 11, 213-9 (2010).
25. Chen, D. et al. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 22, 1753-7 (2008).
26. Imai, S. Dissecting systemic control of metabolism and aging in the NAD World: the importance of SIRT1 and NAMPT-mediated NAD biosynthesis. FEBS Lett. 585, 1657-62 (2011).
27. Mori, V. et al. Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues. PLos One 9, e113939 (2014).
28. Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M. & Sinclair, D. A. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 277, 45099-107 (2002).
29. Bai, P. et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13, 461-8 (2011).
30. Barbosa, M. T. P. et al. The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J. 21, 3629-39 (2007).
31. Hassa, P. O., Buerki, C., Lombardi, C., Imhof, R. & Hottiger, M. O. Transcriptional coactivation of nuclear factor-kappaB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J. Biol. Chem. 278, 45145-53 (2003).
32. Yeung, F. et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369-80 (2004).
33. Rajamohan, S. B. et al. SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1. Mol. Cell. Biol. 29, 4116-29 (2009).
34. Baur, J. A. et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-42 (2006).
35. Kaeberlein, M. et al. Substrate-specific activation of sirtuins by resveratrol. J. Biol. Chem. 280, 17038-45 (2005).
36. Pacholec, M. et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem. 285, 8340-51 (2010).
37. Beher, D. et al. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem. Biol. Drug Des. 74, 619-24 (2009).
38. Vaquero, A. et al. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 20, 1256-61 (2006).
39. Lombard, D. B. et al. Mammalian Sir2 Homolog SIRT3 Regulates Global Mitochondrial Lysine Acetylation. Mol. Cell. Biol. 27, 8807-8814 (2007).
40. Boutant, M. & Cantó, C. SIRT1 metabolic actions: Integrating recent advances from mouse models. Mol. Metab. 3, 5-18 (2014).
41. Xu, F. et al. Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+ /- mice: a role of lipid mobilization and inflammation. Endocrinology 151, 2504-14 (2010).
42. Purushotham, A. et al. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 9, 327-38 (2009).
43. Li, Y. et al. Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. FASEB J. 25, 1664-79 (2011).
44. Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 22, 659-61 (2008).
45. Quiñones, M. et al. Low-molecular procyanidin rich grape seed extract exerts antihypertensive effect in males spontaneously hypertensive rats. Food Res. Int. 51, 587-595 (2013).
46. Puiggros, F. et al. Grape seed procyanidins prevent oxidative injury by modulating the expression of antioxidant enzyme systems. J. Agric. Food Chem. 53, 6080-6 (2005).
47. Arola-Arnal, A. & Bladé, C. Proanthocyanidins modulate microRNA expression in human HepG2 cells. PLos One 6, e25982 (2011).
48. Quesada, I. M. et al. Grape seed procyanidins inhibit the expression of metallothione in genes in human HepG2 cells. Genes Nutr. 2, 105-109 (2007).
49. Ribas-Latre, A., Del Bas, J. M., Baselga-Escudero, L., Casanova, E., Arola-Arnal, A., Salvadó, M. J. & Bladé, C. L. A. Dietary proanthocyanidins modulate the rhythm of BMAL1 expression and induce RORα transactivation in HepG2 cells. J. Funct. Foods 13, 336-344 (2015).
50. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-8 (2001).
51. Becatti, M. et al. SIRT1 modulates MAPK pathways in ischemic-reperfused cardiomyocytes. Cell. Mol. Life Sci. 69, 2245-60 (2012).
52. Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497-509 (1957).